350
Participants
Start Date
July 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
ABT-874
SQ injection 200 mg Weeks 0 and 4; 100 mg Week 8
etanercept
SQ injection 50 mg BIW
placebo
SQ placebo injections for ABT-874 and etanercept
Site Reference ID/Investigator# 10241, New York
Site Reference ID/Investigator# 9787, Rochester
Site Reference ID/Investigator# 10581, Wilmington
Site Reference ID/Investigator# 9902, Hickory
Site Reference ID/Investigator# 15201, Alpharetta
Site Reference ID/Investigator# 9789, Snellville
Site Reference ID/Investigator# 10262, Newnan
Site Reference ID/Investigator# 10762, Atlanta
Site Reference ID/Investigator# 10503, Jacksonville
Site Reference ID/Investigator# 10266, Miami
Site Reference ID/Investigator# 9901, Miami
Site Reference ID/Investigator# 10501, West Palm Beach
Site Reference ID/Investigator# 9984, Birmingham
Site Reference ID/Investigator# 10605, Birmingham
Site Reference ID/Investigator# 10643, Knoxville
Site Reference ID/Investigator# 10265, Louisville
Site Reference ID/Investigator# 15750, Owensboro
Site Reference ID/Investigator# 9790, Owensboro
Site Reference ID/Investigator# 10504, Dayton
Site Reference ID/Investigator# 15142, Plainfield
Site Reference ID/Investigator# 9788, Fort Gratiot
Site Reference ID/Investigator# 10604, Grand Blanc
Site Reference ID/Investigator# 10321, Milwaukee
Site Reference ID/Investigator# 10541, Fridley
Site Reference ID/Investigator# 10666, Maywood
Site Reference ID/Investigator# 10641, St Louis
Site Reference ID/Investigator# 10606, Omaha
Site Reference ID/Investigator# 10644, Omaha
Site Reference ID/Investigator# 10502, Little Rock
Site Reference ID/Investigator# 9981, Dallas
Site Reference ID/Investigator# 9982, Webster
Site Reference ID/Investigator# 10264, San Antonio
Site Reference ID/Investigator# 10001, Scottsdale
Site Reference ID/Investigator# 14701, Los Angeles
Site Reference ID/Investigator# 10662, Santa Monica
Site Reference ID/Investigator# 9785, San Diego
Site Reference ID/Investigator# 10661, Irvine
Site Reference ID/Investigator# 9985, Bakersfield
Site Reference ID/Investigator# 10642, Vallejo
Site Reference ID/Investigator# 10182, Seattle
Site Reference ID/Investigator# 10263, New Haven
Site Reference ID/Investigator# 9786, Berlin
Collaborators (1)
Paragon Biomedical
INDUSTRY
AbbVie (prior sponsor, Abbott)
INDUSTRY